Skip to main content
SpringerLink
Log in

Design and application of antisense oligonucleotides in cell culture,in vivo, and as therapeutic agents

  • Contemporary Techniques
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Summary

1. Synthetic oligonucleotides can inhibit the expression of a gene in a sequence specific manner on the transcriptional and translational level. These molecules are usually referred to as antisense oligonucleotides.

2. Antisense mediated inhibition of gene expression is a valuable tool to analyze the function of a genein vivo and can also be used for therapeutic gene suppression.

3. A number of factors such as the mode of action, specificity, chemistry, and pharmacology must be carefully considered for the design and successful application of antisense oligonucleotides.

4. Assay systems and controls must be chosen as to assure that the observed biological effects of antisense oligonucleotides do in fact reflect the result of a specific gene inhibition.

5. This article critically discusses these factors in view of the literature and our own experience with a wide range of cell types and animal models, targeting different genes. The emphasis is on the use of phosphorothioate oligodeoxynucleotides in cell cultures,in vivo, and as potential drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Akabayashi, A., Wahlestedt, C., Alexander, J. T., and Leibowitz, S. F. (1994). Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion.Mol. Brain Res. 2155–61.

    PubMed  Google Scholar 

  • Bennett, C. F., Condon, T. P., Grimm, S., Chan, H., and Chain, M.-Y. (1994). Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides.J. Immunol. 1523530–3540.

    PubMed  Google Scholar 

  • Breslauer, K. J., Frank, R., Blocker, H., and Marky, L. A. (1986). Predicting DNA duplex stability from the base sequence.Proc. Natl. Acad. Sci. USA 833746–3750.

    PubMed  Google Scholar 

  • Brysch, W., Magal, E., Louis, J. C., Kunst, M., Klinger, I., Schlingensiepen, R., and Schlingensiepen, K.-H. (1994a). Inhibition of p185/c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation.Cancer Gene Ther. 199–105.

    PubMed  Google Scholar 

  • Brysch, W., Rifai, A., Tischmeyer, W., and Schlingensiepen, K.-H. (1994b). Rational drug design, pharmacokinetics and organ uptake of antisense phosphorothioate oligodeoxynucleotidesin vivo. InAntisense Oligonucleotide Therapy: Current Status (S. Agrawal, Ed.), Humana Press, Totowa (in press).

    Google Scholar 

  • Budker, V., Knorre, D., and Vlassov, V. (1991). Cell membranes as barriers for antisense constructions.Antisense Res. Dev. 2177–184.

    Google Scholar 

  • Caceres, A., and Kosik, K. S. (1990). Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons.Nature 343461–463.

    PubMed  Google Scholar 

  • Campbell, J. M., Bacon, T. A., and Wickstrom, E. (1990). Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid.J. Biochem. Biophys. Methods 20259–267.

    PubMed  Google Scholar 

  • Cazenave, C., and Hélène, C. (1991). Antisense oligonucleotides. InAntisense Nucleic Acids and Proteins. Fundamentals and Applications (J. N. M. Mol and A. R. van der Krol, Eds.), Dekker, New York, p. 47ff.

    Google Scholar 

  • Cazenave, C., Loreau, N., Toulmé, J. J., and Hélène C. (1986). Anti-messenger oligodeoxynucleotides: Specific inhibition of rabbitβ-globin synthesis in wheat germ extracts and Xenopus oocytes.Biochimie 68 1063–1073.

    PubMed  Google Scholar 

  • Chiasson, B. J., Hooper, M. L., Murphy, P. R., and Robertson, H. A. (1993). Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain.Eur. J. Mol. Pharmacol. 227451–453.

    Google Scholar 

  • Chiang, M. Y., Chan, H., Zounes, M. A., Freier, S. M., Lima, W. F., and Bennett, C. F. (1991). Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.J. Biol. Chem. 266162–171.

    Google Scholar 

  • Chubb, J. M., and Hogan, M. E. (1993). Human therapeutics based on triple helix technology.TIBTECH 10132–136.

    Google Scholar 

  • Dagle, J. M., Walder, J. A., and Weeks, D. L. (1990). Targeted degradation of mRNA in Xenopus oocytes and embryos directed by modified oligonucleotides: studies of An2 and cyclin in embryogenesis.Nucleic Acids Res. 184751–4757.

    PubMed  Google Scholar 

  • Eckstein, F. (1983). Phosphorothioate analogues of nucleotides—Tools for the investigation of biochemical processes.Angewandte Chem. 22423–506.

    Google Scholar 

  • Freier, S. M., Kierzek, R., Jaeger, J. A., Sugimoto, N., Caruthers, M. H., Neilson, T., and Turner, D. H. (1986). Improved free-energy parameters for predictions of RNA duplex stability.Proc. Natl. Acad. Sci. USA 839373–9377.

    PubMed  Google Scholar 

  • Gewirtz, A. M., and Calabretta, B. (1988). Ac-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesisin vitro.Science 2421303–1306.

    PubMed  Google Scholar 

  • Goodchild, J., Kim, B., and Zamecnik, P. C. (1991). The clearance and degradation of oligodeoxynucleotides following intravenous injection into rabbits.Antisense Res. Dev. 1153–160.

    PubMed  Google Scholar 

  • Guinosso, C. J., Hoke, G. D., Ecker, D. J., Mirabelli, C. K., Crooke, S. T., and Cook, P. D. (1991). Synthesis, biophysical and biological evaluation of 2′-modified antisense oligonucleotides.Nucleosides Nucleotides 10259–265.

    Google Scholar 

  • Heilig, M., Engel, J. A., and Söderpalm, B. (1993). C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine.Eur. J. Pharmacol. 236339–340.

    PubMed  Google Scholar 

  • Helm, C. W., Shrestha, K., Thomas, S., Shingleton, H. M., and Miller, D. M. (1993). A unique c-myc-targeted triplex-forming oligonucleotide inhibits the growth of ovarian and cervical carcinomas in vitro.Gynecol. Oncol. 49339–343.

    PubMed  Google Scholar 

  • Huang, Z., Schneider, K. C., and Benner, S. A. (1991). Building blocks for analogues of ribo- and deoxyribonucleotides with dimethylene-sulfide, -sulfoxide, and -sulfone groups replacing phosphodiester linkages.J. Org. Chem. 563869–3882.

    Google Scholar 

  • Jachimczak, P., Bogdahn, U., Schneider, J., Behl, C., Meixensberger, J., Apfel, R., Dörries, R., Schlingensiepen, K.-H., and Brysch, W. (1993). TGF-beta2-specific phosphorothioate-antisense oligodeoxynucleotides may reverse cellular immunosuppression in malignant glioma.J. Neurosurg. 78944–951.

    PubMed  Google Scholar 

  • Kitajima, I., Shinohara, T., Bilakovics, J., Brown, D. A., Xu, X., and Nerenberg, M. (1993). Ablation of transplanted HTLV-I tax-transformed tumors in mice by antisense inhibition of NF-kappa B.Science 2591523.

    PubMed  Google Scholar 

  • Kulka, M., Smith, C. C., Aurelian, L., Fishelevich, R., Meade, K., Miller, P., and Ts'o, P. O. (1989). Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4.Proc. Natl. Acad. Sci. USA 866868–6872.

    PubMed  Google Scholar 

  • LeDoan, T., Perrouault, L., Praseuth, D., Habhoub, N., Decout, J., Thuong, T., Lhomme, J., and Hélène, C. (1987). Sequence-specific recognition, photocrosslinking and cleavage of the DNA double helix by an oligo-[alpha]-thymidylate covalently linked to an azidoproflavine derivative.Nucl. Acids Res. 157749–7760.

    PubMed  Google Scholar 

  • Miller, P. S., McFarland, K. B., Jayaraman, K., and Ts'o, P. O. P. (1981). Biochemical and biological effects of non-ionic nucleic acid methylphosphonates.Biochemistry 201874–1880.

    PubMed  Google Scholar 

  • Mirabelli, C. K., Bennett, C. F., Anderson, K., and Crooke, S. T. (1991). In vitro and in vivo pharmacologic activities of antisense oligonucleotides.Anticancer Drug Des. 6647–661.

    PubMed  Google Scholar 

  • Morrison, R. S. (1991). Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes.J. Biol. Chem. 266728–734.

    PubMed  Google Scholar 

  • Morvan, F., Rayner, B., Imbach, J. L., Thenet, S., Bertrand, J. R., Paoletti, J., Malvy, C., and Paoletti, C. (1987). Alpha-DNA II. Synthesis of unnatural alpha-anomeric oligodeoxyribonucleotides containing the four usual bases and study of their substrate activities for nucleases.Nucleic Acids Res. 153421–3437.

    PubMed  Google Scholar 

  • Morvan, F., Porumb, H., Degols, G., Lefebvre, I., Pompon, A., Sproat, B. S., Rayner, B., Malvy, C., Lebleu, B., and Imbach, J. L. (1993). Comparative evalution of seven oligonucleotide analogues as potential antisense agents.J. Med. Chem. 36280–287.

    PubMed  Google Scholar 

  • Moser, H. E., and Dervan, P. B. (1987). Sequence-specific cleavage of double helical DNA by triple helix formation.Science 238645–660.

    PubMed  Google Scholar 

  • O'Keefe, S. J., Wolfes, H., Kiessling, A. A., and Cooper, G. M. (1989). Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg.Proc. Natl. Acad. Sci. USA 867038–7042.

    PubMed  Google Scholar 

  • Perbost, M., Lucas, M., Chavis, C., Pompon, A., Baumgartner, H., Rayner, B., Griengl, H., and Imbach, J. L. (1989). Sugar modified oligonucleotides. I. Carbooligodeoxynucleotides as potenaial antisense agents.Biochem. Biophys. Res. Commun. 165742–747.

    PubMed  Google Scholar 

  • Postel, E., Flint, S. J., Kessler, D. J., and Hogan, M. E. (1991). Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels.Proc. Natl. Acad. Sci. USA 888227–8331.

    PubMed  Google Scholar 

  • Reed, J. C., Cuddy, M., Haldar, S., Croce, C., Nowell, P., Makover, D., and Bradley, K. (1990). BCL2-mediated tumorigenicity of a human T-lymphoid cell line: Synergy with MYC and inhibition by BCL2 antisense.Proc. Natl. Acad. Sci. USA 873660–3664.

    PubMed  Google Scholar 

  • Schlingensiepen, K.-H., Schlingensiepen, R., Kunst, M., Klinger, I., Gerdes, W., Seifert, W., and Brysch W. (1993). Opposite functions ofjun-B and c-jun in growth regulation and neuronal differentiation.Dev. Genet 14305–312.

    PubMed  Google Scholar 

  • Schlingensiepen, K.-H., Wollnik, F., Kunst, M., Schlingensiepen, R., Herdegen, T., and Brysch, W. (1994). The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death and in plastic adaptations in-vivo.Cell. Mol. Neurobiol. 14487–505.

    PubMed  Google Scholar 

  • Stein, C. A., and Cheng, Y. C. (1993). Antisense oligonucleotides as therapeutic agents—Is the bullet really magical?Science 2611004–1012.

    PubMed  Google Scholar 

  • Stein, C. A., Mori, K., Loke, S. L., Subasinghe, C., Shinozuka, K., Cohen, J. S., and Neckers, L. M. (1988). Phosphorothioate and normal oligodeoxyribonucleotides with 5′-linked acridine: characterization and preliminary kinetics of cellular uptake.Gene 72333–341.

    PubMed  Google Scholar 

  • Stephenson, M., and Zamecnik, P. C. (1978). Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.Proc. Natl. Acad. Sci. USA 75285–288.

    PubMed  Google Scholar 

  • Strauss, M., Hering, S., Lieber, A., Herrmann, G., Griffin, B. E., and Arnold, W. (1992). Stimulation of cell division and fibroblast focus formation by antisense repression of retinoblastoma protein synthesis.Oncogene 7769–773.

    PubMed  Google Scholar 

  • Tischmeyer, W., Grimm, R., Schicknick, H., Brysch W., and Schlingensiepen, K.-H. (1994). Sequence-specific impairment of learning by c-jun antisense oligonucleotides.Neuroreport 51501–1504.

    PubMed  Google Scholar 

  • Vickers, T., Baker, B. F., Cook, P. D., Zounes, M. Buckheit, R. W., Jr, Germany, J., and Ecker, D. J. (1991). Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.Nucleic Acids Res. 193359–3368.

    PubMed  Google Scholar 

  • Wahlestedt, C., Golanov, E., Yamamoto, S., Yee, F., Ericson, H., Yoo, H., Inturrisi, C. E., and Reis, D. J. (1993a). Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infractions.Nature 363260–263.

    PubMed  Google Scholar 

  • Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F., and Heilig, M. (1993b). Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.Science 259528–531.

    PubMed  Google Scholar 

  • Whitesell, L., Geselowitz, D. Chavany, C., Fahmy, B., Walbridge, S., Alger, J. R., and Neckers, L. M. (1993). Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: Implications for therapeutic application within the central nervous system.Proc. Natl. Acad. Sci. USA 90 4665–4669.

    PubMed  Google Scholar 

  • Wickstrom, E. (1986). Oligodeoxynucleotide stability in subcellular extracts and culture media.J. Biochem. Biophys. Methods 1397–102.

    PubMed  Google Scholar 

  • Wollnik, F., Brysch, W., Uhlmann, E., Gillardon, F., Bravo, R., Zimmermann, M., Schlingensiepen, K.-H., and Herdegen, T. (1994). Block of c-fos andjunB expression by antisense-oligonucleotides inhibits light-induced phase shifts of the mammalian circadian clock.Eur. J. Neurosci. (in press).

  • Zhang, M., and Creese, I. (1993). Antisense oligodeoxynucleotide reduced brain dopamine D2 receptors: Behavioral correlates.Neurosci. Lett. 161223–226.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biognostik Ltd., Carl-Giesecke-Str.3, 37079, Göttingen, Germany

    Wolfgang Brysch

  2. Laboratory of Molecular Tumor- and Neurobiology, Dept 110, Max-Planck-Institut für Biophysikalische Chemie, Am Faßberg, 37077, Göttingen, Germany

    Karl-Hermann Schlingensiepen

Authors
  1. Wolfgang Brysch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karl-Hermann Schlingensiepen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brysch, W., Schlingensiepen, KH. Design and application of antisense oligonucleotides in cell culture,in vivo, and as therapeutic agents. Cell Mol Neurobiol 14, 557–568 (1994). https://doi.org/10.1007/BF02088837

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02088837

Key words

Search

Navigation